SES AI Corporation

Hello everyone, the SES AI First Quarter 2025 earnings base and call will begin shortly. If you would like to ask a question, please press star followed by 1 on your telephone keypad. Thank you for your patience. Thank you for your patience. Hello everyone, and welcome to the SES AI First Quarter 2025 earnings release and call. My name is Nadia and I'll be coordinating the call today. If you would like to ask a question, please press star followed by 1 on your telephone keypad. I will now hand over to your host, Kyle Pilkington, Chief Legal Officer to begin. Kyle, please go ahead.

Hello everyone, and welcome to our conference call covering our First Quarter 2025 results. Joining me today are Qiqiao Hu, Founder and Chief Executive Officer, and Jing Neelis, Chief Financial Officer. We issued our shareholder letter yesterday afternoon after market closed, which provides a business update as well as our financial results. You'll find a press release with a link to our shareholder letter in today's conference call webcast in the investor relations section of our website at SES.AI. Before we get started, this is a reminder that the discussion today may contain forward-looking information or forward-looking statements within the meaning of applicable securities legislation. These statements are based on our predictions and expectations as of today. Such statements involve certain risks, assumptions, and uncertainties, which may cause our actual or future results and performance to be materially different from those expressed or implied in these statements. The risks and uncertainties that could cause our results to differ materially from our current expectations include, but are not limited to, those detailed in the latest earnings release and in our SEC filings. This morning, we will review our business as well as results for the quarter. With that, I'll pass it over to Chi-Chiu.

Thanks, Kyle. Good morning and thank you for joining us on our first quarter 2025 earnings call. In the first quarter, SES.AI achieved a new record for revenue with $5.8 million. This was a great start to what we expect will be a transformational year for SES.AI. In addition, we have announced a battery materials discovery software and service platform. And on April 29th, we will be launching our Molecular Universe demonstration at 11 a.m. You can find more details on our website. First, EV. During the first quarter, we booked revenue from contracts with two OEM partners to develop AI-enhanced lithium metal and lithium ion batteries for EVs. And some highlights include, we are on track to complete B sample and in discussion about commercial next steps with two OEMs. We have deployed our AI for Science material discovery -to-end capability to develop new electrolytes to improve critical battery performance measures, such as cyclized and safety of lithium metal and silicon lithium ion batteries for two OEMs. And based on the successful track record with these two OEMs, we are packaging our AI for Science material discovery -to-end capability into a software and service platform called Molecular Universe. This allows us to mass produce material discovery and development service, our largest and most profitable revenue component, enabling us to rapidly expand our service from just one chemistry and only two OEMs in one market to potentially all OEMs, all battery makers, all electrical companies, consumer electronics companies, and many more across all battery chemistries. And with fierce global EV competition and new safety regulations, through our material discovery and development services, we can deliver commercially practical winning solutions that help OEMs differentiate. And even before the global release of Molecular Universe, there are already one dozen companies, including OEMs, battery and electrical companies, doing early access testing. And now to UAM, drones and robotics. I'm very excited about the tremendous response we have received following our introduction of the AI-enhanced 2170 symmetrical cell for humanoid robotics and drones applications. We also produced pop cells for customers in drones and UAM from our own lines that were previously converted from EVA sample lines. In particular, the strategic value of our facility in Chungju, South Korea, has proven to be particularly valuable to many of our customers, given the current geopolitical uncertainty and tariff tension. Also, these cells use the electrical materials discovered through Molecular Universe. I would like to turn to the upcoming launch of our Molecular Universe software and service platform, as I mentioned, will be released on April 29. The motivation for Molecular Universe is to mass produce Material Discovery and Development Services, our largest and most profitable revenue component. This platform delivers commercially practical winning solutions that help users compete. Molecular Universe is not contract R&D, rather it's an -to-end service ranging from material discovery to cell manufacturing. It is A-sample, B-sample, C-sample, SLP at scale. Its benefits are not just applicable to one chemistry, lithium metal, and one market, EV, but can be applied to all battery chemistries and all battery markets. We will have the global release of the first version of Molecular Universe, MU0, on April 29. The live demo will explain MU0's features and pricing structures. We look forward to reporting more progress and details on the Molecular Universe during the second quarter. To close, I would like to highlight some of our plans for 2025 and beyond. First, we are in a strong cash position to execute on our vision. We have evolved from manufacturing CAPEX-heavy plans for EV and UAM at scale to a scalable software and service business model. We have focused our operating costs on enhancing our commercial team to pursue greater opportunities to expand revenue in 2025 to 2027. Our new Molecular Universe software and service platform has proven to be successful with two OEMs already, and can more efficiently deliver commercially practical winning solutions to all OEMs across all battery chemistries, both lithium metal and silicon lithium ion. We expect the Molecular Universe platform to allow us to rapidly grow our largest and most profitable revenue component. So thank you for your continued interest in SES AI, and now I'll turn it over to Jean for financial updates.

Good morning, everyone. I will discuss our financial performance for the first quarter of 2025 and provide some context on how we are managing capital to support SES's long-term growth strategy. Revenue for the first quarter was $5.8 million. With this strong start to the year, we remain on track to achieve our full year 2025 revenue guidance of $15 million to $25 million. Our Q1 revenue was primarily driven by contracts with our automotive OEM customers to develop AI-enhanced lithium metal and lithium ion batteries for EV applications. Importantly, we delivered a strong growth margin of 79% in Q1, which is consistent with our expectations. The high margin profile is largely a result of our asset life business model, driven by our OEM on AI strategy. Our gap operating expenses were $27.8 million for the quarter. We utilized $22.8 million in cash for operations and invested $0.9 million in capital expenditures during the quarter. We concluded the quarter with a strong liquidity position of $240 million with no debt. As we look ahead to the remainder of 2025, our focus remains on this planned execution and building the foundation for long-term and scalable growth. We're seeing top-line growth, maintaining a strong growth margin, executing our plan efficiently, and position the business for the next phase of commercial readiness. In summary, we are operating from a position of strength, growing top-line revenue, controlling costs, and deploying capital with discipline. We expect to exit 2025 with more than $200 million in liquidity. We appreciate your continued support and confidence in SCSAI. Now I will turn the call back to the operator.

Thank you. If you would like to ask a question, please press star, followed by one on your telephone keypad. If you would like to remove your question, please press star, followed by two. When preparing to ask your question, please ensure your phone is unmuted locally. Our first question goes to Jed Dorsheimer of William Blair. Jed, please go ahead.

Hi, Chih-Chow. You have Mark Shooter on for Jed. Can you remind us of what cell type, the chemistry, and the capacity of your SK facility? Because it seems as though that will be a strategic location now given the tariffs. So what is your strategy there to maximize the value of that facility?

The CJ facility, Chungju facility in South Korea. So it has two lines. It has a sample line that we built with the GMJDA and then that got converted to large Pout cells and then also a smaller UAM cell. So we have two Pout cell lines. But then also because of the new trend, we can also add additional equipment to accommodate cylindrical as well as prismatic cells.

Okay, thank you. And another one here is some of your competitors are pursuing a similar strategy using excess Chinese capacity for 2170 cells and with silicon. Can you remind us of the performance benefits from SCF's 2170s with your improved electrolyte? And can you remind us of the performance and how you compared it to others?

Yeah, so most 2170 cells today have 5.5 or less empowers and that's typically less than 30% silicon. And then if you go to more silicon, if you get to 6.5 empowers and even more than 7 empowers, then you do need more silicon. And then the current electrolyte is not stable and the cycle is short. And also a lot of times the electrolyte has FEC and that tends to gas and then pop the lid. So our electrolyte actually works really well with high content silicon. So we're talking about enabling the stable performance and no gas for 2170 that can achieve more than 6.5 empowers and even 7 empowers.

That's great. Thank you. I do one more if I could see. Yeah, sure. The customer type who would be interested in the molecular universe AI. What types of customers are you engaged with outside of your two main partners?

Yeah, that's actually really exciting. And then for now, I mean, just the first version is just electrolyte. We're talking about all the major battery companies like tier ones and tier twos. We have more than a dozen early access users already before Tuesday launch next Tuesday, but also car companies. So a lot of these battery companies and car companies and also some chemical and electrical companies are really excited about this.

Great. Thank you, Choo Chow. Yeah, thanks, Mark.

The next question goes to Winnie Dong of Deutsche Bank. Winnie, please go ahead.

Hi, good morning. Thanks so much for taking my question. I guess the first one is on maybe just rationale for the authorization of the share buyback. And then the second one is I know you're going to do a morning death session for the pricing related details for the molecular universe AI. So, I'm just wondering if you can give us a teaser on the pricing structure that you guys have in mind for that and how you plan to sort of roll that out to customers for access and potentially for some recurring revenue. Thank you.

Sure. So I can go over the pricing structure first. I'll go over the pricing structure first and then you do the buyback. So the pricing structure for molecular universe, it has basically we have five tiers and then they are divided into pure software and also software plus servers. So pure software. So it's basically for a subscription per user per month and then you can get access to partial molecular universe, the whole molecular universe, different properties and also you can interact with it and then ask questions. And then these are specific commercial challenges that you face in the market. And then the servers is, for example, some of the large enterprise want us to do on prem deployment. Or we actually train this model with the customer's proprietary database. And also in some cases, once we find molecules and then they ask us to synthesize molecules, actually formulate your electrolyte, test the molecules in the batteries like A sample, B sample, basically the full JDA. And then once we discover new molecules and then we can file IP, we can also hide the molecules in what's called hidden galaxies from other users for a fee. So it's a mix of one time fee that includes the on prem install setup and then recurring in the form of subscription to this tool. As well as once we find this molecule, this is almost like the royalty payment for us to to hide the molecules. So, June, if you want to go over the buyback.

Hi, I want to answer your first question. So first I wanted to just reaffirming our 2025 revenue guidance and our strong balance sheet as we expect to exit the year with more than 200 million in liquidity. And also we're on a strong revenue growth path while maintaining the high margin and controlling cost. We believe just that the share repurchase program would be an efficient capital allocation tool for us. The potential use of the capital would not impact our liquidity runway going forward.

Thank you, Winnie. The next question goes to John Roy of Water Tower Research. John, please go ahead.

Thank you very much. I'm interested in the cadence of the revenue through the year. Is it going to be mostly back and loaded? Obviously, it's growing. Just want to get an idea of how you think it might ramp through the year and then also how that might play into 2026. I'm not asking for guidance, but just kind of a view.

Yes, you.

I want me to take it. I can answer that. So we at the beginning of the year, when we gave the guidance, we mentioned that we don't give them this is the first year for us to have a full year revenue. We don't want to. Put a quarterly cadence there, but having said that, I think is more stable and we are on track to achieve our guidance that we provided, which is. Twenty twenty five revenue between fifteen to twenty five million based on our existing pipeline of revenue. We are very confident that we will achieve that goal. If not beyond. I think for twenty twenty six, not to provide guidance or anything, but this year is very foundational year, transformational year for us. We're laying all the groundwork foundation to significantly grow our revenue in twenty twenty six.

Excellent and one follow up question on molecular universe. I guess one of the things that we're all kind of interested in is how we measure the success of that going forward. Are you going to be giving us backlog users? I mean, obviously, you've got twelve people looking at it now. That's great. Just wanted to think about how we should measure success of that.

Well, I think it will come down to revenue, right? Revenue we generate from molecular universe. That's the ultimate metric for success. And also, I think just from a battery industry perspective, we're talking about replacing and accelerating R&D. So if this becomes really successful, I think this will be a tremendous tool to help battery companies and car companies. Instead of hiring thousands of people and spend five years on the new technology, I think you can do that with just ten people and then a few months. So really accelerates development of new technology.

And maybe one final question then. And thank you for that answer. Gross margins medium and long term. Obviously, if you're selling more and more software that might trend up, but seventy nine percent is pretty good already. Is that kind of what you're thinking in your longer models is something in the seventy to eighty percent range? I

think. Yeah.

Go ahead. So the margin, depending on the mix of services and products, I think. Given we're rolling out the software and services, those have a very, very good margin above eighty percent. And we are we also sell products. Those are more like twenty to thirty percent. So going forward is a mix of both. But regardless, we're looking at a mix of about sixty percent margin.

Great. Thank you so much.

Thank

you.

Thank you. There appear to be no additional questions. This now concludes today's call. Thank you for joining. You may now disconnect your line.